| Date Filed | Type | Description |
| 06/16/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 600 shares
@ $0 |
|
| 06/12/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 725 shares
@ $0
Gifted 650 shares
@ $0
Gifted 725 shares
@ $0 |
|
| 06/05/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 2,091 shares
@ $22.97, valued at
$48k
Granted 2,091 shares
@ $0 |
|
| 05/11/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 30,000 shares
@ $23.87, valued at
$716.1k
Sold 14,000 shares
@ $24.07, valued at
$337k
|
|
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 60,586 shares
@ $24.07, valued at
$1.5M
Exercised 45,000 options to buy
@ $1.92, valued at
$86.4k
Exercised 60,000 options to buy
@ $3.29, valued at
$197.4k
|
|
| 02/14/2023 |
5
| Robb Gary Charles (Chief Business Officer) has filed a Form 5 on CORCEPT THERAPEUTICS INC |
| 11/23/2022 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 4,814 shares
@ $26.03, valued at
$125.3k
Sold 186 shares
@ $26.03, valued at
$4.8k
|
|
| 11/21/2022 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $26.06, valued at
$260.6k
Sold 13,401 shares
@ $26.43, valued at
$354.2k
|
|
| 09/08/2022 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 50,000 shares
@ $26.06, valued at
$1.3M
|
|
| 09/06/2022 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 1,010 shares
@ $25.98, valued at
$26.2k
Granted 1,010 shares
@ $0 |
|
| 09/01/2022 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 93,922 shares
@ $26.14, valued at
$2.5M
Exercised 167,323 options to buy
@ $2.08, valued at
$348k
|
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
5
| Robb Gary Charles (Chief Business Officer) has filed a Form 5 on CORCEPT THERAPEUTICS INC |
| 02/11/2022 |
4
| Robb Gary Charles (Chief Business Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 200,000 options to buy
@ $19.26, valued at
$3.9M
|
|
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 258,739 shares
@ $28.06, valued at
$7.3M
Exercised 451,852 options to buy
@ $2.7, valued at
$1.2M
|
|
| 11/17/2020 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 829 shares
@ $0 |
|
| 02/12/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2019 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 30,000 shares
@ $13.7343, valued at
$412k
Exercised 30,000 options to buy
@ $1.92, valued at
$57.6k
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2018 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 25,000 shares
@ $19.0061, valued at
$475.2k
Exercised 25,000 options to buy
@ $1.92, valued at
$48k
|
|
| 02/09/2018 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 200,000 options to buy
@ $16.52, valued at
$3.3M
|
|
| 01/30/2018 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 748 shares
@ $0 |
|
| 12/11/2017 |
4
| Robb Gary Charles (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Gifted 820 shares
@ $0 |
|
|